Gilead's remdesivir is not recommended for patients hospitalized with COVID-19, regardless of how ill they are, as there is no evidence the drug improves survival or reduces the need for ventilation, a World Health Organization panel said on Friday.
source https://www.cbc.ca/news/health/who-remdesivir-trial-1.5809424?cmp=rss
No comments:
Post a Comment